ACTIVE

V-Bio Fund 1

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-3,6 M €+60,6 %over 1 year
Gross margin-903,7 k €+2,1 %over 1 year
Equity37,1 M €-8,9 %over 1 year

Identity

Source · BCE/KBO

V-Bio Fund 1 is a Public limited company incorporated in 2015. Its main activity is: Activities of holding companies. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0642.766.540
Incorporation
09/11/2015
Legal form
Public limited company
Registered office
Pieter van Reysschootlaan 2 box 104
9051 Gent · FlandreSee on map
Contributed capital
60 081 813,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 10 filings

Trend over 6 financial years

20252024202320222021
Income statement
Gross margin-903,7 k €-923 k €-949,3 k €-834,2 k €-724,3 k €
EBITDA-905,1 k €-924,3 k €-950,5 k €-835,5 k €-725,4 k €
Operating result-905,1 k €-924,3 k €-950,5 k €-835,5 k €-725,4 k €
Net result-3,6 M €-9,2 M €-4,8 M €8,5 M €-1,3 M €
Balance sheet
Equity37,1 M €40,7 M €45,2 M €43 M €39,3 M €
Total assets37,2 M €40,8 M €45,2 M €43 M €39,3 M €
Cash931,1 k €2,6 M €3,7 M €1,1 M €2 M €
Debts41,8 k €12,1 k €9,1 k €5,1 k €4,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

V-BIO MANAGEMENT 1

Mandate · 0641.986.877

Represented by Christina Takke

Active

Ended mandates

V-BIO MANAGEMENT 1

Director · since 06 novembre 2015 · until 31 décembre 2027 · 0641.986.877

Represented by Christina Takke

Ended
V-BIO MANAGEMENT 1

Manager · since 06 novembre 2015 · until 31 décembre 2017 · 0641.986.877

Represented by Willem Broekaert

Ended

Other companies at this address

Pieter van Reysschootlaan 2 9051 Gent
CompanyCBE no.
AMON CONSULTANTS● Active
0886.996.605
CD-Vastgoed● Active
0465.063.827
HONEY COMPANY● Active
0793.625.294
Tanai Therapeutics● Active
1002.228.546
V-Bio Co-Invest 1-1● Active
0712.738.182
V-Bio Fund 2● Active
0759.685.291
V-BIO MANAGEMENT 1● Active
0641.986.877
V-Bio Management 2● Active
0758.543.760
V-BIO PARTNERS 1● Active
0641.850.186
V-Bio Partners 2● Active
0758.543.661
V-Bio Ventures● Active
0758.544.057
Vereniging van mede-eigenaars van het kantorencomplex VAN REYSSCHOOT te Gent - Sint-Denijs-Westrem, Pieter van Reysschootlaan 2● Active
0839.676.936

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date18/06/202602/06/202526/06/202423/06/202329/12/202207/06/2021
General meeting27/05/202628/05/202529/05/202431/05/202325/05/202226/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202527/05/202618/06/2026DutchPDF
Abridged model31/12/202428/05/202502/06/2025DutchPDF
Micro model31/12/202329/05/202426/06/2024DutchPDF
Micro model31/12/202231/05/202323/06/2023DutchPDF
Micro model31/12/202125/05/202229/12/2022DutchPDF
Micro model31/12/202026/05/202107/06/2021DutchPDF
Micro model31/12/201912/06/202009/07/2020DutchPDF
Micro model31/12/201829/05/201902/08/2019DutchPDF
Micro model31/12/201730/05/201811/06/2018DutchPDF
Abridged model31/12/201631/05/201712/09/2017DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

V-BIO MANAGEMENT 1

Mandate · 0641.986.877

Represented by Christina Takke

Active

Ended mandates

V-BIO MANAGEMENT 1

Director · since 06 novembre 2015 · until 31 décembre 2027 · 0641.986.877

Represented by Christina Takke

Ended
V-BIO MANAGEMENT 1

Manager · since 06 novembre 2015 · until 31 décembre 2017 · 0641.986.877

Represented by Willem Broekaert

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares21/04/2026
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares29/10/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares10/07/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates17/11/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares19/07/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares25/03/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates14/10/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/12/2019
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-3,6 M €↑
  2. 2024
    Annual accounts 2024-9,2 M €↓
  3. 2023
    Annual accounts 2023-4,8 M €↓
  4. 2022
    Annual accounts 20228,5 M €↑
  5. 2022
    Name changeV-Bio Fund 1
  6. 2021
    Annual accounts 2021-1,3 M €↑
  7. 2021
    Name changeV-Bio Fund 1 Private Privak
  8. 2017
    Annual accounts 2017-1,6 M €
  9. 2017
    Name changeV-Bio Ventures Fund 1 ARKIV
  10. 09/11/2015
    IncorporationPublic limited company